Cumulative Serum Uric Acid and its Time Course Are Associated with Risk of Myocardial Infarction and All-Cause Mortality
And guessing with a tirzepatide dose is not something anyone should accept
In the context of risk of confounding by indication, propensity score matching was not expected to provide additional reduction of residual confounding beyond the applied covariate adjustment (psychiatric, somatic, and sociodemographic factors) and self-controlled analyses [33]
For refractory OIC in the setting of GLP-1 therapy, peripherally acting mu-opioid receptor antagonists (PAMORAs) like naloxegol (25 mg daily) may be appropriate [6]
Tell Us Your StoryHave you experienced any side effects from GLP-1s you weren't expecting
Instead, the market becomes highly complex and deeply segmented, shaped by body mass index, comorbidities, and by differences in patient profiles and preferences, including route of administration, dosing frequency and tolerability